Biohit Oyj (HEL:BIOBV)
Finland · Delayed Price · Currency is EUR 2.680
-0.020 (-0.74%)
Aug 7, 2026, 5:26 PM EET
Biohit Oyj Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3.1 | 2.74 | 2.57 | 1.85 | 0.6 | -1.5 |
Depreciation & Amortization | 0.6 | 0.54 | 0.34 | 0.36 | 0.48 | 1.99 |
Other Adjustments | 0.4 | 0.52 | 0.46 | 0.22 | 0.73 | 0.11 |
Change in Receivables | - | -4.85 | -2.25 | -1.39 | -0.03 | -1.4 |
Changes in Inventories | - | 0.22 | -0.13 | 0.03 | -0.17 | 0.16 |
Changes in Accounts Payable | - | 0.18 | -0.15 | -0.02 | 0.55 | 0.21 |
Changes in Income Taxes Payable | -0.1 | -0.1 | -0.25 | -0.16 | -0.31 | -0.02 |
Changes in Other Operating Activities | -5 | -4.45 | -2.53 | -1.38 | 0.35 | -1.02 |
Operating Cash Flow | -1.1 | -0.75 | 0.59 | 0.9 | 1.85 | -0.44 |
Operating Cash Flow Growth | - | - | -35.03% | -51.19% | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.9 | -0.62 | -0.4 | -0.25 | -0.06 | -0.03 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.02 |
Purchases of Investments | - | -0.11 | -1.02 | -2.83 | -2.9 | -1.59 |
Proceeds from Sale of Investments | - | 1.59 | 1.52 | 2.43 | 2.33 | 2.37 |
Other Investing Activities | -0 | -0.16 | 0.41 | -0.07 | 1.04 | 0.05 |
Investing Cash Flow | -0.9 | 0.87 | 0.08 | -0.71 | -0.63 | 0.76 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Issuance of Common Stock | - | 0.02 | 0.07 | 0.07 | - | - |
Net Common Stock Issued (Repurchased) | - | 0.02 | 0.07 | 0.07 | - | - |
Other Financing Activities | -0.3 | -0.3 | -0.3 | -0.27 | -0.19 | -0.27 |
Financing Cash Flow | -0.3 | -0.29 | -0.23 | -0.2 | -0.19 | -0.27 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | -0.05 | 0.04 | 0.01 | -0.02 | 0.01 |
Net Cash Flow | -2.4 | -0.21 | 0.47 | 0 | 1.02 | 0.06 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2 | -1.36 | 0.18 | 0.65 | 1.79 | -0.48 |
Free Cash Flow Growth | - | - | -71.86% | -63.44% | - | - |
FCF Margin | -12.42% | -8.68% | 1.29% | 5.00% | 16.34% | -5.10% |
Free Cash Flow Per Share | -0.13 | -0.09 | 0.01 | 0.04 | 0.12 | -0.03 |
Levered Free Cash Flow | -2.3 | -1.52 | -0.55 | 0.45 | 1.45 | -0.21 |
Unlevered Free Cash Flow | -2.3 | -1.52 | -0.83 | 0.14 | 1.63 | -0.41 |